Phase II Trial of Lonafarnib (a Farnesyltransferase Inhibitor) for Progeria

Clinical trial NCT00425607 · COMPLETED

Trial details

NCT number: NCT00425607
Sponsor: Monica E. Kleinman
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Progeria Hutchinson-Gilford Syndrome

Start date: 2007-05-01
Primary completion: 2009-10-01
Enrollment: 29

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.